Nivolumab is a monoclonal antibody and is a humanized PD-1 antibody. Nivolumab has anti-tumor activity and is used in the treatment of melanoma, non-small cell lung cancer, renal cell carcinoma, etc.
Molecular Weight:
146 kDa
Purity:
98.00%
CAS Number:
[946414-94-4]
Target:
PD-1/PD-L1
T9907
* VAT and and shipping costs not included. Errors and price changes excepted